Sector consensus Cytokinetics, Incorporated

Stocks

Real-time Estimate Cboe BZX Other stock markets 18:23:36 11/06/2026 BST			5-day change	1st Jan Change
69.54 ^USD	+3.69%		-3.65%	+9.62%

06-09	Cytokinetics, Incorporated Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 09:18 AM
06-02	Cytokinetics Insider Sold Shares Worth $1,111,200, According to a Recent SEC Filing	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
CYTOKINETICS, INCORPORATED			104.7	+56.11%	20
ARGENX SE			846.68	+10.97%	15
WUXI APPTEC CO., LTD.			145.96	+50.41%	16
BIONTECH SE			106.48	+43.68%	19
INSMED INCORPORATED			198.1	+115.6%	21
WUXI BIOLOGICS (CAYMAN) INC.			40.49	+57.97%	22
GENMAB A/S			2,313.13	+43.85%	15
EXELIXIS, INC.			49	-6.81%	16
PHARMAESSENTIA CORPORATION			810.5	-17.8%	6
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			547.64	+36.43%	17
SUMMIT THERAPEUTICS INC.			21.28	+118.4%	13
MADRIGAL PHARMACEUTICALS, INC.			679.29	+44.12%	14
AKESO, INC.			148.87	+95.8%	20
ARROWHEAD PHARMACEUTICALS, INC.			88.17	+24.65%	12
NUVALENT, INC.			128.41	+4.1%	17
IMMUNITYBIO, INC.			13	+86.25%	3
REMEGEN CO., LTD.			99.79	+64.9%	15
BIOCON LIMITED			414.05	-0.13%	20
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	770,000	+83.77%	1
VAXCYTE, INC.			109	+139.98%	9
Average			38,843.23	+52.61%	15
Weighted average by Cap.			17,879.1	+45.64%	16